183 related articles for article (PubMed ID: 23182454)
1. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.
Zuckerman V; Sokolov E; Swet JH; Ahrens WA; Showlater V; Iannitti DA; Mckillop IH
Oncotarget; 2016 Jan; 7(3):2951-67. PubMed ID: 26701886
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
Lou L; Chen YX; Jin L; Li X; Tao X; Zhu J; Chen X; Wu S; Ye W; He J; Ding G
J Int Med Res; 2013 Feb; 41(1):55-63. PubMed ID: 23569130
[TBL] [Abstract][Full Text] [Related]
4. Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy.
Simo KA; Niemeyer DJ; Hanna EM; Swet JH; Thompson KJ; Sindram D; Iannitti DA; Eheim AL; Sokolov E; Zuckerman V; McKillop IH
HPB (Oxford); 2014 Jun; 16(6):534-42. PubMed ID: 24750398
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
7. Study of lysophosphatidic acid receptors (LPARs) in buffalo uterus demonstrated upregulation of LPAR1 and LPAR6 in early pregnancy.
Sadam A; Parida S; Padol AR; Verma AD; Baba NA; Khuman WM; Srivastava V; Panigrahi M; Singh TU; Sarkar SN
Theriogenology; 2017 Sep; 99():90-97. PubMed ID: 28708504
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells.
Dietze R; Starzinski-Powitz A; Scheiner-Bobis G; Tinneberg HR; Meinhold-Heerlein I; Konrad L
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1369-1377. PubMed ID: 30591146
[TBL] [Abstract][Full Text] [Related]
9. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid.
Fernandes MF; Tomczewski MV; Duncan RE
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456981
[TBL] [Abstract][Full Text] [Related]
12. Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
Gnocchi D; Kapoor S; Nitti P; Cavalluzzi MM; Lentini G; Denora N; Sabbà C; Mazzocca A
J Mol Med (Berl); 2020 Feb; 98(2):179-191. PubMed ID: 31863151
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells.
Chou CH; Lai SL; Ho CM; Lin WH; Chen CN; Lee PH; Peng FC; Kuo SH; Wu SY; Lai HS
PLoS One; 2015; 10(3):e0122060. PubMed ID: 25822713
[TBL] [Abstract][Full Text] [Related]
14. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma.
Mazzocca A; Dituri F; De Santis F; Filannino A; Lopane C; Betz RC; Li YY; Mukaida N; Winter P; Tortorella C; Giannelli G; Sabbà C
Cancer Res; 2015 Feb; 75(3):532-43. PubMed ID: 25589345
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
[TBL] [Abstract][Full Text] [Related]
17. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.
Leve F; Peres-Moreira RJ; Binato R; Abdelhay E; Morgado-Díaz JA
PLoS One; 2015; 10(9):e0139094. PubMed ID: 26418031
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY
Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisphenol A and 4-nonylphenol on cellular responses through the different induction of LPA receptors in liver epithelial WB-F344 cells.
Dong Y; Araki M; Hirane M; Tanabe E; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2014 Jun; 34(3):201-4. PubMed ID: 24460192
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
